Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Benzene, 4-bromo-1-chloro-2-(phenoxymethyl)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

879403-77-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 879403-77-7 Structure
  • Basic information

    1. Product Name: Benzene, 4-bromo-1-chloro-2-(phenoxymethyl)-
    2. Synonyms:
    3. CAS NO:879403-77-7
    4. Molecular Formula: C13H10BrClO
    5. Molecular Weight: 297.579
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 879403-77-7.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: Benzene, 4-bromo-1-chloro-2-(phenoxymethyl)-(CAS DataBase Reference)
    10. NIST Chemistry Reference: Benzene, 4-bromo-1-chloro-2-(phenoxymethyl)-(879403-77-7)
    11. EPA Substance Registry System: Benzene, 4-bromo-1-chloro-2-(phenoxymethyl)-(879403-77-7)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 879403-77-7(Hazardous Substances Data)

879403-77-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 879403-77-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,9,4,0 and 3 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 879403-77:
(8*8)+(7*7)+(6*9)+(5*4)+(4*0)+(3*3)+(2*7)+(1*7)=217
217 % 10 = 7
So 879403-77-7 is a valid CAS Registry Number.

879403-77-7Downstream Products

879403-77-7Relevant articles and documents

NOVEL SGLT INHIBITORS

-

Paragraph 0107, (2017/06/23)

The present invention relates to novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synt

NOVEL SGLT INHIBITORS

-

Page/Page column 49, (2013/03/28)

The present invention relates to novel compounds of Formula (I), their pharmaceutically acceptable derivatives, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the sy

NOVEL SGLT INHIBITORS

-

Page/Page column 53, (2013/02/28)

The present invention relates to novel compounds of Formula (I), their pharmaceutically acceptable derivatives, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of Formula (I), their pharmaceutically acceptable derivatives, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of Formula (I) and methods of treating or preventing one or more conditions or diseases that may be regulated or normalized via inhibition of Sodium Glucose Cotransporter-2 (SGLT-2).

GLUCOPYRANOSYL-SUBSTITUTED DIFLUOROBENZYL-BENZENE DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR MANUFACTURE

-

Page/Page column 37, (2010/11/30)

Glucopyranosyl-substituted difluorobenzyl-benzene derivatives of general formula (I) as defined according to claim 1, including the tautomers, the stereoisomers thereof, the mixtures thereof and the salts thereof. The compounds according to the invention

Processes for preparing of glucopyranosyl-substituted (ethynyl-benzyl)-benzene derivatives and intermediates thereof

-

Page/Page column 27, (2010/11/26)

The present invention relates to processes for preparing the compounds of general formula I, wherein the groups R1, R2 and R3 are defined according to claim 1 and to intermediates of said processes.

Heck, direct arylation, and hydrogenation: Two or three sequential reactions from a single catalyst

Leclerc, Jean-Philippe,Andre, Mathieu,Fagnou, Keith

, p. 1711 - 1714 (2007/10/03)

Palladium-catalyzed tandem multifunctional reactions leading to the synthesis of substituted biaryl molecules have been developed including tandem Heck-direct arylation and tandem-sequential Heck-direct arylation-hydrogenation. These reactions occur in go

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 879403-77-7